D.E. Shaw & Co
WX

D.E. Shaw & Co’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

D.E. Shaw & Co’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,812
Closed -$597K – 4112
2015
Q3 		$597K Sell
13,812
-4,061
-23% -$171K ﹤0.01% 2944
2015
Q2 		$755K Sell
17,873
-6,088
-25% -$257K ﹤0.01% 2900
2015
Q1 		$929K Buy
+23,961
New +$923K ﹤0.01% 2620
2014
Q4 		– Sell
-11,770
Closed -$412K – 4474
2014
Q3 		$412K Buy
+11,770
New +$403K ﹤0.01% 3497
2014
Q2 		– Sell
-28,515
Closed -$1.05M – 4812
2014
Q1 		$1.05M Sell
28,515
-79,377
-74% -$2.91M ﹤0.01% 2984
2013
Q4 		$4.14M Sell
107,892
-217,056
-67% -$6.85M 0.01% 1856
2013
Q3 		$8.9M Buy
324,948
+46,914
+17% +$1.11M 0.01% 1104
2013
Q2 		$5.84M Buy
+278,034
New +$5.43M 0.01% 1242

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

D.E. Shaw & Co's WX Position: Q4 2015 in Review

D.E. Shaw & Co sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 13,812 shares — an estimated $597K sold.

D.E. Shaw & Co first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $8.9M in Q3 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • D.E. Shaw & Co reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 13,812 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $597K.
  • D.E. Shaw & Co first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
  • D.E. Shaw & Co's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $8.9M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on D.E. Shaw & Co's 13F filing for Q4 2015, filed 16 Feb 2016.